Bruna holds a BSc in Pharmacy (2018) and a MSc in Biosciences (2020), both at the Federal University of Health Sciences of Porto Alegre (UFCSPA), Brazil. She is currently a PhD candidate at the University of Bergen (UiB) in Norway and a member of Ruth Brenk’s research group at the UiB’s Biorecognition Unit.
As a researcher of the MepAnti consortium, Bruna is responsible for virtual and fragment screenings for the first five enzymes of the MEP pathway, DXS, DXR, IspD, IspE, and IspF. The goal is to discover new inhibitors for these targets. The interplay of theoretical and experimental methods is a key point to refine the validation of the potential inhibitors found.